Publication | Closed Access
Final results from a phase II trial of ZD1839 ("Iressa") for patients with advanced non-small-cell lung cancer (IDEAL 1)
171
Citations
0
References
2002
Year
Final ResultsPhase Ii TrialAdvanced Lung DiseaseMedicineClinical TrialsIdeal 1Cancer TreatmentOncologyRadiation OncologyLung CancerRadiologyHealth Sciences
No additional data available for this publication yet. Check back later!